Security key
682310875
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)
CUSIP: 682310875
Q4 2018 13F Holders as of 31 Dec 2018
- Type / Class
- Equity / Common Stock, no par value
- Shares outstanding
- 109,272,143
- Total 13F shares
- 156,055
- Share change
- -28,727
- Total reported value
- $282,469
- Price per share
- $1.78
- Number of holders
- 15
- Value change
- -$180,670
- Number of buys
- 5
- Number of sells
- 9
Report period
Q4 2018
Institutions
15
Top holders
10
ONCY full security history
Newer quarter: Q1 2019
Previous quarter: Q3 2018
ONCOLYTICS BIOTECH INC SEC filings
ONCOLYTICS BIOTECH INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 682310875
Recent filing periods:
Top shareholders of ONCY - ONCOLYTICS BIOTECH INC - Common Stock, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
53,320
|
$206,000 | — | 30 Sep 2018 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.04%
|
46,563
|
$180,000 | — | 30 Sep 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
16,000
|
$62,000 | — | 30 Sep 2018 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.01%
|
15,800
|
$61,000 | — | 30 Sep 2018 | |
| COMERICA BANK |
13F
|
Company |
0.01%
|
15,526
|
$48,000 | — | 30 Sep 2018 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
12,262
|
$47,000 | — | 30 Sep 2018 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.01%
|
7,985
|
$30,576 | — | 30 Sep 2018 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
6,053
|
$24,000 | — | 30 Sep 2018 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
4,843
|
$18,000 | — | 30 Sep 2018 | |
| Intellectus Partners, LLC |
13F
|
Company |
0%
|
2,105
|
$8,000 | — | 30 Sep 2018 | |
| NEXT Financial Group, Inc |
13F
|
Company |
0%
|
1,893
|
$7,000 | — | 30 Sep 2018 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
1,390
|
$6,000 | — | 30 Sep 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
642
|
$2,000 | — | 30 Sep 2018 | |
| Patriot Financial Group Insurance Agency, LLC |
13F
|
Company |
0%
|
600
|
$2,000 | — | 30 Sep 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
577
|
$2,000 | — | 30 Sep 2018 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
409
|
$2,000 | — | 30 Sep 2018 | |
| TORONTO DOMINION BANK |
13F
|
Company |
0%
|
210
|
$1,000 | — | 30 Sep 2018 | |
| American Portfolios Advisors |
13F
|
Company |
0%
|
105
|
$403 | — | 30 Sep 2018 |
Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q4 2018
As of 31 Dec 2018,
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
156,055 shares.
The largest 10 holders included
MORGAN STANLEY, SCOTIA CAPITAL INC., COMERICA BANK, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Federation des caisses Desjardins du Quebec, ROYAL BANK OF CANADA, BANK OF MONTREAL /CAN/, NEXT Financial Group, Inc, DEUTSCHE BANK AG\, and HUNTINGTON NATIONAL BANK.
This page lists
15
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2018 vs Q3 2018 Across Filers
Q3 2018 holders
16
Q4 2018 holders
15
Holder diff
-1
| Investor | Q3 2018 Shares | Q4 2018 Shares | Share Diff | Share Chg % | Q3 2018 Value $ | Q4 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.